McMahon J B, Beutler J A, O'Keefe B R, Goodrum C B, Myers M A, Boyd M R
Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702-1201, USA.
J Biomol Screen. 2000 Jun;5(3):169-76. doi: 10.1177/108705710000500309.
The unique, high-affinity binding of cyanovirin-N (CV-N), a potent anti-human immunodeficiency virus (HIV) protein, to the HIV envelope glycoprotein gp120, was exploited to develop an HTS assay in an attempt to discover small-molecule mimetics of CV-N. A competition binding assay was developed using CV-N labeled with europium (Eu(3+)). The labeling protocol did not significantly alter the gp120 binding properties or the antiviral activity of CV-N. This report describes the assay development, validation, and results of screening a large library of aqueous and organic natural product extracts. The extracts were incubated with immobilized recombinant gp120 in 96-well plates prior to the addition of Eu(3+)-labeled CV-N. Following a wash step, bound CV-N was measured by dissociation-enhanced time-resolved fluorometry of Eu(3+). The assay proved to be robust, rapid, and reproducible, and was used to screen over 50,000 natural product extracts, and has resulted in the identification of several aqueous natural product extracts that inhibited CV-N-gp120 binding and also had anti-HIV activity.
氰苷 - N(CV - N)是一种有效的抗人类免疫缺陷病毒(HIV)蛋白,它与HIV包膜糖蛋白gp120具有独特的高亲和力结合,利用这一特性开发了一种高通量筛选(HTS)检测方法,试图发现CV - N的小分子模拟物。使用铕(Eu(3+))标记的CV - N开发了一种竞争结合检测方法。标记方案并未显著改变CV - N的gp120结合特性或抗病毒活性。本报告描述了该检测方法的开发、验证以及对大量水性和有机天然产物提取物文库进行筛选的结果。在添加Eu(3+)标记的CV - N之前,将提取物与固定在96孔板中的重组gp120一起孵育。经过洗涤步骤后,通过Eu(3+)的解离增强时间分辨荧光法测量结合的CV - N。该检测方法被证明是稳健、快速且可重复的,用于筛选超过50,000种天然产物提取物,并已鉴定出几种抑制CV - N - gp120结合且具有抗HIV活性的水性天然产物提取物。